Novel Dual Action Receptors Antagonists (Dara) at the Ati and Eta Receptors
申请人:Gupta Ramesh Chandra
公开号:US20100010035A1
公开(公告)日:2010-01-14
The present invention relates to new compounds of the formula [Chemical formula should be inserted here. Please see paper copy] wherein R1, R2, R3, and R31 are as specified herein. The invention also relates to a method for preparation thereof, as well as combinations of the new compounds with previously known agents. The invention also relates to the use of the above-mentioned compounds and combinations for the preparation of a medicament for treating hypertension of different kinds, alleviating organ damage of different kinds, treating or preventing diabetic nephropathy, treating endothelin and angiotensin mediated disorders, and treating prostate cancer.
HETEROCYCLE ANALOGS OF CAI-1 AS AGONISTS OF QUORUM SENSING IN VIBRIO
申请人:The Trustees of Princeton University
公开号:US20180078526A1
公开(公告)日:2018-03-22
A structurally distinct and potent series of synthetic small molecule activators of
Vibrio cholerae
quorum sensing have been chemically synthesized. The small molecule activators reduce virulence in
V. cholerae
. Acyl pyrrole molecules displayed strong potency and stability, particularly 1-(1H-pyrrol-3-yl)decan-1-one.
[EN] NOVEL ISOTHIAZOL-3-YL AND ISOXAZOL-3-YL SULFONAMIDE COMPOUNDS<br/>[FR] NOUVEAUX COMPOSÉS ISOTHIAZOL-3-YL ET ISOXAZOL-3-YL SULFONAMIDE
申请人:HOFFMANN LA ROCHE
公开号:WO2024017855A1
公开(公告)日:2024-01-25
The invention relates to novel compounds having the general formula (I) wherein R1, R2, R3, X and Y are as described herein, composition including the compounds and methods of using the compounds.
本发明涉及具有通式(I)(其中 R1、R2、R3、X 和 Y 如本文所述)的新型化合物、包括这些化合物的组合物以及使用这些化合物的方法。